Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings

March 9, 2018 updated by: Melva Louisa

Efficacy and Safety of Aluminaid Versus Hydrogel Wound Dressings in the Treatment of Partial Thickness Burns

Burn injury is the result of an energy transfer that destroys the skin and adjacent tissues. Partial thickness burn wounds are painful and difficult to manage. The aim of burn treatment in partial thickness burns is to promote rapid wound healing, decrease pain, protect wound from infections, minimize scar formation and functional impairment In recent years, there are progressive development of new dressing material with a variety of option for depth adapted wound management. Many wound dressings are available for superficial and partial thickness burns. Hydrogel based wound dressing provides good biocompatibility with the skin and mucosa and promotes hydration of the wound bed.

Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium that was designed to reduce acute pain in the treatment of superficial and partical thickness burn injuries.

Up to date, no evidence regarding integrated with aluminium sheet in hydrogel based wound dressings for the use in partial thickness burns. Therefore this trials is aimed to evaluate the efficacy and safety of Aluminaid versus Hydrogel for the treatment of partial thickness burns.

Study Overview

Status

Terminated

Detailed Description

This is a prospective, randomized, open label, active controlled trial that aim to evaluate the efficacy and safety of Aluminaid versus Hydrogel wound dressings in the treatment of partial thickness burns.

The study is a multi center trial in children and adults of 12 - 65 years old with partial thickness burns.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jakarta
      • Jakarta Pusat, Jakarta, Indonesia, 10430
        • Clinic of Clinical Research Supporting Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 63 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults and children of 12 - 65 years old
  • Partial thickness thermal burns of minimally 1% total body surface area (TBSA)
  • Admission of less than 4 hours of burn injury
  • Patients/legal guardian still have the ability to undergo examinations and give written informed consent.

Exclusion Criteria:

  • Total body surface area (TBSA) of more than 20%
  • Burns caused by chemicals, electricity or radiation
  • Superficial and partial thickness burns located on the faces, palms, soles, genitalia, perineum and joint areas
  • Superficial and partial thickness burns with compartment syndrome
  • Superficial and partial thickness burns with a history of life-threatening trauma
  • Had concomitant disease such as diabetes mellitus
  • Signs of infected burns
  • Patients with known allergies to product containing aluminium, hydrogel or a history of contact dermatitis
  • Other conditions which according to the investigator's judgment are not appropriate to be included in the study.
  • Treated with other agents before attend to clinic (oil, tooth paste, betadine, rivanol etc)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aluminaid
Treatment group: Aluminaid wound dressing
Aluminaid wound dressings is a hydrogel based wound dressing that is integrated with aluminium
Active Comparator: Hydrogel
Hydrogel wound dressing (Trademark: Burnshield)
Hydrogel based wound dressing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound healing
Time Frame: Up to 21 days
Wound healing as determine by the time of complete re-epithelization of the study area, in days.
Up to 21 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Erythema
Time Frame: at the time of admission up to 30 minutes
The presence of erythema
at the time of admission up to 30 minutes
Bullae
Time Frame: at the time of admission up to 30 minutes
The presence of bullae
at the time of admission up to 30 minutes
Pain score
Time Frame: At the time of admission up to 30 minutes and 1st week of follow up
Pain score is determined by VAS score (1 - 10: 1 is no pain 10 is severe pain).
At the time of admission up to 30 minutes and 1st week of follow up
Adverse events
Time Frame: At the time of admission up to 21 days of follow up
The adverse events in patients treated with Aluminaid versus Hydrogel as determined by the proportion of patients who experience adverse events
At the time of admission up to 21 days of follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Wawaimuli Arozal, MD, PhD, Indonesia University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

March 5, 2018

Study Completion (Actual)

March 5, 2018

Study Registration Dates

First Submitted

June 12, 2017

First Submitted That Met QC Criteria

June 14, 2017

First Posted (Actual)

June 19, 2017

Study Record Updates

Last Update Posted (Actual)

March 12, 2018

Last Update Submitted That Met QC Criteria

March 9, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Aluminaid

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Partial-thickness Burn

3
Subscribe